Renub Research has recently published a report named “France In-Vitro Diagnostics (IVD) Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028,” providing a detailed industry analysis that consists of market share insights. Furthermore, the report encompasses a study of competitors and regions and the recent growth in the Market.
Expert Insights: Ask Analyst or Download Full Report with TOC & Figures: https://www.renub.com/france-in-vitro-diagnostics-market-p.php
France In-Vitro Diagnostics Market shall grow at a CAGR of 5.10% from 2022-2028. In-vitro diagnostics (IVD) refers to medical devices and laboratory instruments used to perform tests on samples taken from the human body, like blood, tissue, and urine, to diagnose diseases and monitor medical conditions. These tests are performed outside the body in a laboratory or a clinical setting. Examples of IVD tests include blood glucose monitoring, pregnancy testing, and cancer screening.
The World Health Organization (WHO) reports that France has a diabetes diagnosis rate of nearly one million cases. According to Renub Research, the population distribution in France as of January 1st, 2023, individuals under 15 comprised more than 17 Percent of the total population, while those aged 75 and older accounted for approx 10 percent.
The France in-vitro diagnostics (IVD) market is growing due to a number of factors. These includerising prevalence of chronic diseases, Advancements in diagnostic technologies, focus on developing healthcare infrastructure and presence of reimbursement policies for diagnostic tests. However, in the France in-vitro diagnostics (IVD) market, challenges such as regulatory complexities, reimbursement issues, fragmented market dynamics, low awareness of in-vitro diagnostics (IVD) benefits, and concerns regarding data privacy and security act as drawbacks.
The services segment shall remain dominant in the France In-Vitro Diagnostics (IVD) Market.
The dominance of services in the France in-vitro diagnostics (IVD) market is due to factors such as crucial support and expertise throughout the testing process, specialized knowledge and skills required for complex testing, customization, and integration into workflows, training, and education programs for healthcare professionals, maintenance and technical support, and the focus on value-based care and evolving healthcare landscape.
Products–France in-vitro diagnostics (IVD) Market breakup from 3 Viewpoints:
PCR tests have sovereignty in the France in-vitro diagnostics (IVD) market.
PCR tests dominate the France in-vitro diagnostics (IVD) market due to their exceptional precision and sensitivity, enabling the detection of diseases and genetic mutations with utmost accuracy. Their versatility in various fields, including diagnostics, research, and disease control, contributes to their widespread acceptance. Rapid turnaround times facilitate prompt diagnosis and treatment, especially in critical situations and outbreaks. Ongoing advancements in PCR technology have enhanced performance, automation, and affordability, ensuring accessibility for healthcare providers. The COVID-19 pandemic has further intensified the demand for PCR tests, firmly establishing them as the preferred method for detecting SARS-CoV-2. In summary, PCR tests’ dominance in the France in-vitro diagnostics (IVD) market is growing due to their accuracy, broad range of applications, fast results, technological advancements, and the influence of the pandemic.
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=france-in-vitro-diagnostics-market-p.php
Test types – France in-vitro diagnostics (IVD) Market breakup from 11 Viewpoints:
- ELISA & CLIA
- Rapid Test
- Fluorescence Immunoassays (FIA)
- In Situ Hybridization
- Transcription Mediated Amplification
- Colorimetric Immunoassay
- Radioimmunoassay (RIA)
- Isothermal Nucleic Acid Amplification Technology
The infectious diseases segment is experiencing significant growth in France in-vitro diagnostics market.
The demand for accurate and timely diagnostics in France is due to public health concerns and the high prevalence of infectious diseases. Rapid and precise diagnosis is essential for effective disease detection, treatment, and preventive measures. Infectious disease diagnostics are also critical during outbreaks and epidemics, guiding control measures and patient management. In addition, regulatory support and initiatives further promote in-vitro diagnostics for infectious diseases. These factors collectively contribute to the dominance of infectious disease diagnostics in the France in-vitro diagnostics (IVD) market.
Application – France in-vitro diagnostics (IVD) Market breakup from 8 Viewpoints:
- Infectious Diseases
- Autoimmune Diseases
- Drug Testing
Molecular diagnostics/genetics will thrive in France’s in-vitro diagnostics (IVD) market.
The growth of molecular diagnostics/genetics in the France in-vitro diagnostics (IVD) market is because of technological advancements, personalized medicine, increasing disease prevalence, comprehensive testing capabilities, supportive regulations, and collaborative efforts within healthcare. These factors improve the accuracy and efficiency of tests, identify genetic variations and biomarkers, and address the rising demand for insights into disease risk, detection, and treatment. In addition, the availability of genetic testing panels and sequencing technologies reduces turnaround times. Favourable policies and reimbursement encourage adoption, while collaborations accelerate research and innovation in clinical practice.
Technology – France in-vitro diagnostics (IVD) Market breakup from 7 Viewpoints:
- Clinical Chemistry
- Molecular Diagnostics/Genetics
Laboratories are slowly gaining popularity in France in-vitro diagnostics (IVD) market.
The growth of laboratories in France IVD market is driven by increasing demand for diagnostic services, technological advancements, specialized expertise, quality standards, personalized medicine, and improved information systems. Rising disease prevalence and accurate diagnoses fuel the demand, with laboratories playing a crucial role. Advancements in technology and automation enhance testing capabilities, especially in molecular diagnostics and genetics. Accreditation ensures quality and confidence in results. Specialized laboratories cater to personalized medicine and precision diagnostics. Integration of information systems improves efficiency and communication.
End-User – France in-vitro diagnostics (IVD) Market breakup from 4 Viewpoints:
- Home – Care
Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation, and QIAGEN N.V. are among the leading companies in the France in-vitro diagnostics market.
Company have been covered from 3 Viewpoints:
2. Recent Development
- Roche Diagnostics
- Abbott Diagnostics
- Siemens Healthineers
- Danaher Corporation
- Thermo Fisher Scientific
- Sysmex Corporation
- QIAGEN N.V
About the Company:
Renub Research is a Market Research and Consulting Company. We have more than 14 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Email: [email protected]